- Home
- JAKK vs LYEL Comparison
JAKK vs LYEL Comparison
Compare JAKK & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAKK
- LYEL
- Stock Information
- Founded
- JAKK 1995
- LYEL 2018
- Country
- JAKK United States
- LYEL United States
- Employees
- JAKK N/A
- LYEL N/A
- Industry
- JAKK Recreational Games/Products/Toys
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- JAKK Consumer Discretionary
- LYEL Health Care
- Exchange
- JAKK Nasdaq
- LYEL Nasdaq
- Market Cap
- JAKK 231.8M
- LYEL 207.7M
- IPO Year
- JAKK 1996
- LYEL 2021
- Fundamental
- Price
- JAKK $18.57
- LYEL $10.76
- Analyst Decision
- JAKK Strong Buy
- LYEL Sell
- Analyst Count
- JAKK 4
- LYEL 2
- Target Price
- JAKK $41.75
- LYEL $15.00
- AVG Volume (30 Days)
- JAKK 151.1K
- LYEL 47.6K
- Earning Date
- JAKK 07-24-2025
- LYEL 08-12-2025
- Dividend Yield
- JAKK 5.71%
- LYEL N/A
- EPS Growth
- JAKK 25.15
- LYEL N/A
- EPS
- JAKK 3.34
- LYEL N/A
- Revenue
- JAKK $684,694,000.00
- LYEL $60,000.00
- Revenue This Year
- JAKK N/A
- LYEL N/A
- Revenue Next Year
- JAKK $4.01
- LYEL N/A
- P/E Ratio
- JAKK $5.55
- LYEL N/A
- Revenue Growth
- JAKK 1.31
- LYEL 11.11
- 52 Week Low
- JAKK $16.24
- LYEL $7.65
- 52 Week High
- JAKK $35.79
- LYEL $32.40
- Technical
- Relative Strength Index (RSI)
- JAKK 56.07
- LYEL 49.97
- Support Level
- JAKK $17.24
- LYEL $10.49
- Resistance Level
- JAKK $17.90
- LYEL $11.00
- Average True Range (ATR)
- JAKK 0.56
- LYEL 0.72
- MACD
- JAKK 0.23
- LYEL -0.11
- Stochastic Oscillator
- JAKK 98.31
- LYEL 52.86
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.